156 related articles for article (PubMed ID: 2293058)
1. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
Heal DJ; Frankland AT; Buckett WR
Neuropharmacology; 1990 Dec; 29(12):1141-50. PubMed ID: 2293058
[TBL] [Abstract][Full Text] [Related]
2. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
Davies CL; Heal DJ
J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383
[TBL] [Abstract][Full Text] [Related]
3. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
Heal DJ; Prow MR; Buckett WR
Br J Pharmacol; 1989 Mar; 96(3):547-56. PubMed ID: 2541844
[TBL] [Abstract][Full Text] [Related]
4. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
5. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
Heal DJ; Frankland AT; Gosden J; Hutchins LJ; Prow MR; Luscombe GP; Buckett WR
Psychopharmacology (Berl); 1992; 107(2-3):303-9. PubMed ID: 1615130
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
9. Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by analysis of dopamine turnover.
Heal DJ; Czudek C; Buckett WR
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):803-21. PubMed ID: 7938568
[TBL] [Abstract][Full Text] [Related]
10. Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites.
Cheng CH; Wooten GF
J Pharmacol Methods; 1982 Sep; 8(2):123-33. PubMed ID: 7144209
[TBL] [Abstract][Full Text] [Related]
11. Alterations in dopamine metabolism by intraperitoneal ethanol in rats selected for high and low ethanol preference: a 3-methoxytyramine study.
Honkanen A; Chrapusta SJ; Karoum F; Korpi ER
Alcohol; 1994; 11(4):323-8. PubMed ID: 7945987
[TBL] [Abstract][Full Text] [Related]
12. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
Karoum F; Chrapusta SJ; Egan MF
J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
[TBL] [Abstract][Full Text] [Related]
13. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
Przegaliński E; Jaworska L; Konarska R; Gołembiowska K
Neuropeptides; 1991 Jul; 19(3):189-95. PubMed ID: 1680223
[TBL] [Abstract][Full Text] [Related]
14. A rapid and simple method for the determination of picogram levels of 3-methoxytyramine in brain tissue using liquid chromatography with electrochemical detection.
Ponzio F; Achilli G; Algeri S
J Neurochem; 1981 Apr; 36(4):1361-7. PubMed ID: 7264632
[TBL] [Abstract][Full Text] [Related]
15. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
Elverfors A; Nissbrandt H
Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
[TBL] [Abstract][Full Text] [Related]
16. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
17. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
Karoum F; Egan MF
Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D1 and D2 receptors and to axotomy.
Nissbrandt H; Hjorth S
J Neural Transm Gen Sect; 1992; 90(1):13-26. PubMed ID: 1361343
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Waldmeier PC; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
[TBL] [Abstract][Full Text] [Related]
20. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
Boldry RC; Uretsky NJ
Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
